KZR KEZAR LIFE SCIENCES INC Capital Structure Changes 8-K Filing 2024 - Stock Split Approved Kezar Life Sciences, Inc. approved a reverse stock split at a ratio of one-for-ten, effective October 29, 2024, to comply with Nasdaq listing requirements, with adjustments to stock options and rights accordingly.Get access to all SEC 8-K filings of the KEZAR LIFE SCIENCES INC